2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿｜IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | MOLECULAR THERAPY MOL THER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.8
62人评分
我要评分
声誉 9.5 影响力 8.2 速度 9.0 | |||||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | 1525-0016 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||||||||||||
| E-ISSN | 1525-0024 | |||||||||||||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 12 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：11.24 | |||||||||||||||||||||||||||||||||||||||||
| 2024-2025自引率 | 1.7%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||||||||||
| 五年影响因子 | 12.4 | |||||||||||||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 2.89 | |||||||||||||||||||||||||||||||||||||||||
| h-index | 158 | |||||||||||||||||||||||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊官方网站 | https://www.cell.com/molecular-therapy-family/molecular-therapy/home | |||||||||||||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/molecular-therapy/default.aspx | |||||||||||||||||||||||||||||||||||||||||
| 作者指南网址 | https://www.cell.com/molecular-therapy-family/molecular-therapy/authors | |||||||||||||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Dual-targeting CD133/PD-L1 CAR-T plus αPD-1 overcomes immunosuppressive microenvironment and enhanced by radiation pre-conditioning Author: Yao, Zhuoran; Kang, Kai; Li, Pei-Heng; Yin, Limei; Tong, Ruizhan; Yi, Linglu; Song, Yonghong; Luo, Ren; Wu, Yijun; Liu, Shanghai; Peng, Zichong; Mo, Xianming; Wang, Wenbo; Xue, Jianxin; Lu, You Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1483-1502. DOI: 10.1016/j.ymthe.2025.12.068 Gene therapy for Bietti crystalline corneoretinal dystrophy: A phase 1/2 clinical trial Author: Yang, Liping; Xing, Dongjun; Zhang, Jinlu; Liu, Boshi; Jiang, Xiaoshuang; Chen, Shaohong; Li, Wang; Qu, Baoyuan; Qiao, Jing; Feng, Xuefeng; Jia, Haicun; Hu, Xianjun; Yu, Shicheng; Jia, Ruixuan; Wang, Likun; Mahajan, Vinit B.; Dou, Hongliang; Lu, Fang; Li, Xiaorong Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1743-1755. DOI: 10.1016/j.ymthe.2026.01.005 On-target/off-tumor toxicities following infusion of low-affinity Nectin-4-specific CAR T cells Author: Ma, Liya; Wang, Jian; Li, Jing; Yang, Wei; Wen, Ming; Yao, Mengjiao; Zhang, Kaiwen; Jiang, Ting; Ren, Fengyi; Liu, Dong; Shen, Minying; Deng, Hao; Hong, Yonggui; Yuan, Shuaiqi; Xia, Xudong; Lu, Xiao; Cao, Heng; Liu, Zhiqiang; Ma, Xingyi; Li, Baozhong; Jason-Sun, Hongxing Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1435-1447. DOI: 10.1016/j.ymthe.2025.12.002 Modulating synovial macrophage responses to nociceptive signals attenuates inflammation in rheumatoid arthritis Author: Lin, Lan; Chen, Yang; Lin, Yiming; Yuan, Xuhui; Huang, Jiexin; Cai, Yuanqing; Zhang, Canhong; Li, Hongyan; Zhang, Chaofan; Lin, Huangfeng; Wu, Baijian; Lv, Jianhua; Yu, Shaolin; Liao, Yuntao; Wu, Zhaoyang; Li, Wenbo; Zhang, Zeyu; Lin, Jianhua; Chang, Cheng; Yang, Bin; Zhang, Wenming; Fang, Xinyu Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1813-1835. DOI: 10.1016/j.ymthe.2025.11.028 | |||||||||||||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足MOLECULAR THERAPY的语言要求，还能让MOLECULAR THERAPY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被MOLECULAR THERAPY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes (Hybrid，可自选是否OA) | |||||||||||||||||||||||||||||||||||||||||
| 通讯方式 | CELL PRESS, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139 | |||||||||||||||||||||||||||||||||||||||||
| 出版商 | Cell Press | |||||||||||||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-生物工程与应用微生物 | |||||||||||||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||||||||||||
| 出版年份 | 2000 | |||||||||||||||||||||||||||||||||||||||||
| 年文章数 | 264点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 27.60% | |||||||||||||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 88.64% | |||||||||||||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-0016%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Time to first decision: 8 days; 网友分享经验： 平均1月 | |||||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较难 | |||||||||||||||||||||||||||||||||||||||||
| APC文章处理费信息 | 版面费：For ASGCT members: $64 per page up to eight printed pages and $128 per page thereafter, additional OA option fee is $3,600; For non-ASGCT members: $116 per page up to eight printed pages and $180 per page thereafter, OA option fee is $4,500; | |||||||||||||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在MOLECULAR THERAPY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||||||||||
| 编辑信息 | Editor-in-Chief Joseph C. Glorioso III, PhD, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA Front matter editor John Bell, PhD, University of Ottawa, Ottawa, Canada | |||||||||||||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Dual-targeting CD133/PD-L1 CAR-T plus αPD-1 overcomes immunosuppressive microenvironment and enhanced by radiation pre-conditioning Author: Yao, Zhuoran; Kang, Kai; Li, Pei-Heng; Yin, Limei; Tong, Ruizhan; Yi, Linglu; Song, Yonghong; Luo, Ren; Wu, Yijun; Liu, Shanghai; Peng, Zichong; Mo, Xianming; Wang, Wenbo; Xue, Jianxin; Lu, You Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1483-1502. DOI: 10.1016/j.ymthe.2025.12.068 PubMed DOI |
| 2. | Gene therapy for Bietti crystalline corneoretinal dystrophy: A phase 1/2 clinical trial Author: Yang, Liping; Xing, Dongjun; Zhang, Jinlu; Liu, Boshi; Jiang, Xiaoshuang; Chen, Shaohong; Li, Wang; Qu, Baoyuan; Qiao, Jing; Feng, Xuefeng; Jia, Haicun; Hu, Xianjun; Yu, Shicheng; Jia, Ruixuan; Wang, Likun; Mahajan, Vinit B.; Dou, Hongliang; Lu, Fang; Li, Xiaorong Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1743-1755. DOI: 10.1016/j.ymthe.2026.01.005 PubMed DOI |
| 3. | On-target/off-tumor toxicities following infusion of low-affinity Nectin-4-specific CAR T cells Author: Ma, Liya; Wang, Jian; Li, Jing; Yang, Wei; Wen, Ming; Yao, Mengjiao; Zhang, Kaiwen; Jiang, Ting; Ren, Fengyi; Liu, Dong; Shen, Minying; Deng, Hao; Hong, Yonggui; Yuan, Shuaiqi; Xia, Xudong; Lu, Xiao; Cao, Heng; Liu, Zhiqiang; Ma, Xingyi; Li, Baozhong; Jason-Sun, Hongxing Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1435-1447. DOI: 10.1016/j.ymthe.2025.12.002 PubMed DOI |
| 4. | Modulating synovial macrophage responses to nociceptive signals attenuates inflammation in rheumatoid arthritis Author: Lin, Lan; Chen, Yang; Lin, Yiming; Yuan, Xuhui; Huang, Jiexin; Cai, Yuanqing; Zhang, Canhong; Li, Hongyan; Zhang, Chaofan; Lin, Huangfeng; Wu, Baijian; Lv, Jianhua; Yu, Shaolin; Liao, Yuntao; Wu, Zhaoyang; Li, Wenbo; Zhang, Zeyu; Lin, Jianhua; Chang, Cheng; Yang, Bin; Zhang, Wenming; Fang, Xinyu Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1813-1835. DOI: 10.1016/j.ymthe.2025.11.028 PubMed DOI |
| 5. | Comparative evaluation of liver-directed knockin strategies with viral and nonviral vectors in mouse inherited disease models Author: Jin, Xiu; Wu, Xiaoyi; Song, Junwei; Luo, Mei; Ye, Qin; Ren, Chengda; Song, Li; Li, Manjun; Hu, Ming; An, Yifang; Su, Jing; Fu, Jiamei; Xu, Qiuxia; Luo, Min; Liu, Fanfei; Liu, Man; Li, Qiqi; Yao, Shaohua; Chen, Lu; Yang, Yang Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1775-1793. DOI: 10.1016/j.ymthe.2025.12.012 PubMed DOI |
| 6. | contributes to the progression of renal fibrosis Author: Hong, Wenkai; Zhao, Bingru; Wu, Wangshu; Song, Ahui; Wang, Minzhou; Lu, Jiayue; Li, Feng; Lu, Renhua; Dai, Huili; Xie, Kewei; Min, Lulin; Gu, Leyi Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1539-1553. DOI: 10.1016/j.ymthe.2025.11.030 PubMed DOI |
| 7. | A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenoviruses Author: Feng, Ying; Shu, Tao; Li, Liang; Sun, Xinxin; Yu, Changfa; Liu, Wenming; Hong, Lingling; Li, Jiashun; Zhao, Shutao; Zeng, Weikai; Yang, Chenchen; Wang, Chunhua; Zheng, Xuehua; Ye, Xianmiao; Sun, Xikui; Liu, Yichu; Li, Zhixia; Chen, Si; Niu, Xuefeng; Zhou, Rong; Li, Pingchao; Feng, Liqiang; Chen, Ling Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1597-1615. DOI: 10.1016/j.ymthe.2025.12.027 PubMed DOI |
| 8. | Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors Author: Chen, Jiannan; Li, Wenying; Wang, Shuai; Li, Jiayi; Zhao, Lianfeng; Ao, Xudong; Wang, Wenyu; Zhu, Li; Rao, Haipeng; Xu, Shichu; Wen, Mengru; Hu, Zhigang; Pan, Feiyan; He, Lingfeng; Gu, Lili; Fang, Weijia; Xu, Shengjing; Liang, Junqing; Zhao, Peng; Chen, Haoyan; Guo, Zhigang Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1448-1464. DOI: 10.1016/j.ymthe.2025.12.021 PubMed DOI |
| 9. | Methylated circPTK2 as a driver of fibroblast activation in pulmonary fibrosis Author: Zhu, Yuguang; Zhao, Lixin; Qin, Jianfeng; Guo, Bingpeng; Luo, Xuedan; Feng, Ziqi; Wei, Juyan; Huang, Xiaolong; Chen, Xiying; Lin, Yonghao; Yin, Feng; Huang, Yongyin; Zhang, Yingyi; Wu, Jiaxiang; Fang, Junyan; Ding, Shangwei; Zhang, Yu; Li, Yangxin; Han, Qian; Shen, Ao; Yu, Xi-Yong Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. 1554-1575. DOI: 10.1016/j.ymthe.2025.12.013 PubMed DOI |
| 10. | Targeting renal tubular WWP2 to restore mitochondrial OXPHOS integrity retards the AKI-to-CKD transition Author: Wu, Mengqiu; Miao, Mengqiu; Li, Yuting; Fan, Jiaojiao; Zhu, Wenping; Niu, Yujia; Liu, Ruotian; Chen, Weiyi; Zou, Ran; Huang, Songming; Zhang, Yue; Bai, Mi; You, Ran; Jia, Zhanjun; Zhang, Aihua Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 3, pp. -. DOI: 10.1016/j.ymthe.2025.11.022 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共203条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
